Early Pregnancy Loss Clinical Presentation

  • Author: Elizabeth E Puscheck, MD; Chief Editor: Richard Scott Lucidi, MD   more...
 
Updated: Jan 26, 2012
 

History

Patients with spontaneous complete abortion usually present with a history of vaginal bleeding, abdominal pain, and passage of tissue. After the tissue passes, the vaginal bleeding and abdominal pain subsides.

  • Vaginal bleeding is usually heavy.
    • Quantification of the amount of bleeding is very important because life-threatening hemorrhage may occur. The patient may be able to quantify the number of pads or tampons used over a specified time and qualify the amount that each pad is soaked. This is just an estimate; yet, soaking a pad or more an hour suggests significant and worrisome amounts of bleeding that require prompt attention. These patients should be sent to the emergency department.
    • The presence of blood clots suggests heavy bleeding. The presence of blood clots also may be confused with passage of tissue.
    • Examining the passed material helps clarify whether the material is clot or tissue. If the material is tissue, then the type of abortion may be identified. If the tissue is evaluated and appears complete, then a complete abortion is confirmed.
  • Abdominal pain is associated with concurrent abortion and resolves with the completion of the abortion.
    • The pain usually is in the suprapubic area, but reports of pain in one or both lower quadrants are not uncommon.
    • The pain may radiate to the lower back, buttocks, genitalia, and perineum.
    • If the pain is occurring only on one side, consider an ectopic pregnancy or a ruptured ovarian cyst as possible causes.
  • Consider any reproductive-aged woman presenting with vaginal bleeding to be pregnant until proven otherwise.
  • Other symptoms, such as fever or chills, are more characteristic of infection, such as in a septic abortion. Septic abortions need to be treated immediately, otherwise they may be life threatening.
Next

Physical

Patients who are pregnant and bleeding vaginally need immediate evaluation.

  • Estimating the patient's hemodynamic stability is the first step.
    • Obtain orthostatic vital signs.
    • Initiate fluid resuscitation early in cases of orthostatic hypotension.
    • Abdominal and pelvic examinations are next.
  • The abdominal examination helps determine whether or not the state of an acute abdomen is present.
    • In a complete abortion, the abdomen is benign, with no distension, no rebound, normal bowel sounds, no hepatosplenomegaly, and mild suprapubic tenderness.
    • Usually, the uterus is either not palpable abdominally or is just slightly above the pubic symphysis in a first-trimester pregnancy loss. The uterus can be enlarged due to other pathology (eg, leiomyomas).
    • If rebound tenderness or a distended abdomen is present, a complete abortion is unlikely. Assume instead that an ectopic pregnancy is present and if rebound tenderness is present, then provide the patient with aggressive fluid resuscitation with 2 IV lines, quantitative hCG, stat ultrasound (if stable enough) and an emergent laparoscopy or an emergent exploratory laparotomy.
  • In the case of a complete abortion, pelvic examination may show some blood on the perineum or vagina but limited active bleeding.
    • Cervical motion tenderness does not exist.
    • The cervical canal is closed.
    • The uterus is smaller than expected for dates, and it is nontender to mildly tender.
    • The adnexa are nontender to mildly tender. Usually, no adnexal masses exist, unless a corpus luteum is still palpable.
    • In summary, the pelvic examination check list includes assessment of the following:
      • Source of bleeding (cervical os)
      • Intensity of bleeding (active, heavy, clots)
      • Any presence or passage of tissue
      • Cervical motion tenderness (increases suspicion for ectopic pregnancy)
      • Cervical os closed for complete or threatened abortion (If it is open, consider inevitable or incomplete abortion.)
      • Uterine size and tenderness
      • Adnexal masses (suspicious for ectopic pregnancy)
Previous
Next

Causes

  • In the first trimester, embryonic causes of spontaneous abortion are the predominant etiology and account for 80-90% of miscarriages (See following image.) Second transvaginal sonogram obtained 1 week afterSecond transvaginal sonogram obtained 1 week after the initial study fails to demonstrate fetal development. This confirms the diagnosis of an embryonic pregnancy.
  • One study suggests that an inflammatory reaction occurs in normal pregnancy and may be disrupted during miscarriage.[7]
  • Genetic abnormalities within the embryo (ie, chromosomal abnormalities) are the most common cause of spontaneous abortion and account for 50-65% of all miscarriages.
    • The most common single chromosomal anomaly is 45,X karyotype, with an incidence of 14.6%.
    • Trisomies are the single largest group of chromosomal anomalies and account for approximately one half of all anomalies associated with miscarriage. Trisomy 16 is the most common trisomy found.
    • Approximately 20% of genetic abnormalities are triploidies.
  • Teratogenic and mutagenic factors may play a role, but quantification is difficult.
  • Maternal causes of spontaneous miscarriage include the following:
    • Genetic: Maternal age is directly related to the aneuploidy risk (>30% in people aged 40 y). Couples with recurrent miscarriages have a 2-3% incidence of a parental chromosomal anomaly (ie, balanced translocation).
    • Structural abnormalities of the reproductive tract include the following:
      • Congenital uterine defects (particularly uterine septum)
      • Fibroids
      • Cervical incompetence
  • Iatrogenic causes (ie, Asherman syndrome)
  • Acute maternal factors include the following:
  • Chronic maternal health factors include the following:
    • Polycystic ovary syndrome
    • Poorly controlled diabetes mellitus (A successful pregnancy requires much tighter control.)
    • Renal disease
    • Systemic lupus erythematosus (SLE)
    • Untreated thyroid disease: A meta-analysis evaluating the association between thyroid autoantibodies and miscarriage and preterm birth in women with normal thyroid function found a strong link between maternal thyroid autoantibodies and miscarriage and preterm birth.[8] Evidence suggests that treatment with levothyroxine may attenuate the risks.
    • Severe hypertension
    • Antiphospholipid syndrome
  • Exogenous factors include the following:
    • Tobacco
    • Alcohol
    • Cocaine
    • Caffeine (high doses)
  • Independent risk factors for a spontaneous miscarriage include the following:[3, 4, 5]
    • Advanced age
    • Extremes of age
    • Feeling stressed
    • Advanced paternal age
  • Symptoms of vaginal bleeding but not abdominal pain are associated with increased risk of miscarriage. One paper suggests that miscarriage can occur in about 50% of patients who present with threatened abortion.
  • NSAID use: Gestational exposure to nonaspirin NSAIDs may increase the risk for miscarriage. Nakhai-Pour et al identified 4705 women who had spontaneous abortions by 20 weeks’ gestation. Each case was matched to 10 control subjects (n=47,050) who did not have a spontaneous abortion. In the women who had a miscarriage, 352 (7.5%) were exposed to a nonaspirin NSAID, whereas NSAID exposure was lower (1213 exposed [2.6%]) in women who did not have a miscarriage.[9]
Previous
 
 
Contributor Information and Disclosures
Author

Elizabeth E Puscheck, MD  Professor, Department of Obstetrics and Gynecology, Wayne State University School of Medicine; In Vitro Fertilization Director, Gynecologic Ultrasound Director, Clinical Endocrine Laboratory Consultant, Department of Obstetrics and Gynecology, University Women's Care

Elizabeth E Puscheck, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Society for Reproductive Medicine, Association of Professors of Gynecology and Obstetrics, Endocrine Society, International Society for Clinical Densitometry, Society for Assisted Reproductive Technologies, Society for Reproductive Endocrinology and Infertility, and Society of Reproductive Surgeons

Disclosure: Wyeth Grant/research funds Other

Specialty Editor Board

Suzanne R Trupin, MD, FACOG  Clinical Professor, Department of Obstetrics and Gynecology, University of Illinois College of Medicine at Urbana-Champaign; CEO and Owner, Women's Health Practice; CEO and Owner, Hada Cosmetic Medicine and Midwest Surgical Center

Suzanne R Trupin, MD, FACOG is a member of the following medical societies: American Association of Gynecologic Laparoscopists, American College of Obstetricians and Gynecologists, American Institute of Ultrasound in Medicine, American Medical Association, Association of Reproductive Health Professionals, International Society for Clinical Densitometry, and North American Menopause Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Richard S Legro, MD  Professor, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Pennsylvania State University College of Medicine; Consulting Staff, Milton S Hershey Medical Center

Richard S Legro, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists, American Society for Reproductive Medicine, Endocrine Society, Phi Beta Kappa, and Society of Reproductive Surgeons

Disclosure: Korea National Institute of Health and National Institute of Health (Bethesda, MD) Honoraria Speaking and teaching; Greater Toronto Area Reproductive Medicine Society (Toronto, ON, CA) Honoraria Speaking and teaching; American College of Obstetrics and Gynecologists (Washington, DC) Honoraria Speaking and teaching; National Institute of Child Health and Human Development Pediatric and Adolescent Gynecology Research Think Tank Panel (Bethesda, MD) Honoraria Speaking and teaching; University of Illinois (Chicago, IL) Honoraria Speaking and teaching; Georgetown University Hospital (Washington, DC) Honoraria Speaking and teaching; Heilongjiang University (Harbin, China) Speaking and teaching; New England Fertility Society (Nashua, NJ) Honoraria Speaking and teaching; William Beaumont Hospital Division of Reproductive Endocrinology and Infertility (Detroit, MI) Honoraria Speaking and teaching; Wayne State University School of Medicine (Detroit MI) Honoraria Speaking and teaching

Frederick B Gaupp, MD  Consulting Staff, Department of Family Practice, Hancock Medical Center

Frederick B Gaupp, MD is a member of the following medical societies: American Academy of Family Physicians

Disclosure: Nothing to disclose.

Chief Editor

Richard Scott Lucidi, MD  Associate Professor of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine

Richard Scott Lucidi, MD is a member of the following medical societies: American College of Obstetricians and Gynecologists and American Society for Reproductive Medicine

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Archana Pradhan, MD, MPH to the development and writing of this article.

References
  1. Barnhart KT, Katz I, Hummel A, Gracia CR. Presumed diagnosis of ectopic pregnancy. Obstet Gynecol. Sep 2002;100(3):505-10. [Medline].

  2. Condous G, Kirk E, Lu C, et al. There is no role for uterine curettage in the contemporary diagnostic workup of women with a pregnancy of unknown location. Hum Reprod. Oct 2006;21(10):2706-10. [Medline].

  3. Arck PC, Rucke M, Rose M, et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online. Jul 2008;17(1):101-13. [Medline].

  4. Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage--results from a UK-population-based case-control study. BJOG. Feb 2007;114(2):170-86. [Medline].

  5. Gracia CR, Sammel MD, Chittams J, Hummel AC, Shaunik A, Barnhart KT. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies. Obstet Gynecol. Nov 2005;106(5 Pt 1):993-9. [Medline].

  6. Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance--United States, 1991--1999. MMWR Surveill Summ. Feb 21 2003;52(2):1-8. [Medline].

  7. Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod. Nov 29 2011;[Medline].

  8. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ. May 9 2011;342:d2616. [Medline]. [Full Text].

  9. Nakhai-Pour HR, Perrine B, Sheehy O, Berard A. Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. CMAJ. September 6, 2011;[Full Text].

  10. Practice Committee of American Society for Reproductive Medicine. Medical treatment of ectopic pregnancy. Fertil Steril. Nov 2008;90(5 Suppl):S206-12. [Medline].

  11. Weeks A, Alia G, Blum J, et al. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol. Sep 2005;106(3):540-7. [Medline].

  12. Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. Aug 25 2005;353(8):761-9. [Medline].

  13. [Guideline] American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 94: Medical management of ectopic pregnancy. Obstet Gynecol. Jun 2008;111(6):1479-85. [Medline]. [Full Text].

  14. Wahabi HA, Fayed AA, Esmaeil SA, Al Zeidan RA. Progestogen for treating threatened miscarriage. Cochrane Database Syst Rev. Dec 7 2011;12:CD005943. [Medline].

  15. Clifford K, Rai R, Regan L. Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod. Feb 1997;12(2):387-9. [Medline].

  16. Liddell HS, Pattison NS, Zanderigo A. Recurrent miscarriage--outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol. Nov 1991;31(4):320-2. [Medline].

  17. Stray-Pedersen B, Stray-Pedersen S. Etiologic factors and subsequent reproductive performance in 195 couples with a prior history of habitual abortion. Am J Obstet Gynecol. Jan 15 1984;148(2):140-6. [Medline].

  18. [Guideline] ACOG practice bulletin. ACOG practice bulletin. Medical management of tubal pregnancy. Number 3, December 1998. Clinical management guidelines for obstetrician-gynecologists. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. Apr 1999;65(1):97-103. [Medline].

  19. Chipchase J, James D. Randomised trial of expectant versus surgical management of spontaneous miscarriage. Br J Obstet Gynaecol. Jul 1997;104(7):840-1. [Medline].

  20. Chung TK, Cheung LP, Sahota DS, Haines CJ, Chang AM. Spontaneous abortion: short-term complications following either conservative or surgical management. Aust N Z J Obstet Gynaecol. Feb 1998;38(1):61-4. [Medline].

  21. Creinin MD, Schwartz JL, Guido RS, Pymar HC. Early pregnancy failure--current management concepts. Obstet Gynecol Surv. Feb 2001;56(2):105-13. [Medline].

  22. Geyman JP, Oliver LM, Sullivan SD. Expectant, medical, or surgical treatment of spontaneous abortion in first trimester of pregnancy? A pooled quantitative literature evaluation. J Am Board Fam Pract. Jan-Feb 1999;12(1):55-64. [Medline].

  23. Hurd WW, Whitfield RR, Randolph JF Jr, Kercher ML. Expectant management versus elective curettage for the treatment of spontaneous abortion. Fertil Steril. Oct 1997;68(4):601-6. [Medline].

  24. Jurkovic D, Ross JA, Nicolaides KH. Expectant management of missed miscarriage. Br J Obstet Gynaecol. Jun 1998;105(6):670-1. [Medline].

  25. Kalousek DK. Clinical significance of morphologic and genetic examination of spontaneously aborted embryos. Am J Reprod Immunol. Feb 1998;39(2):108-19. [Medline].

  26. Katz VL, Lentz G, Lobo RA, Gershenson DM, eds. Comprehensive Gynecology. 5th ed. Philadelphia: Mosby Elsevier; 2007.

  27. Keith SC, London SN, Weitzman GA, O'Brien TJ, Miller MM. Serial transvaginal ultrasound scans and beta-human chorionic gonadotropin levels in early singleton and multiple pregnancies. Fertil Steril. May 1993;59(5):1007-10. [Medline].

  28. Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet. Jan 14 1995;345(8942):84-6. [Medline].

  29. Scroggins KM, Smucker WD, Krishen AE. Spontaneous pregnancy loss: evaluation, management, and follow-up counseling. Prim Care. Mar 2000;27(1):153-67. [Medline].

Previous
Next
 
Second transvaginal sonogram obtained 1 week after the initial study fails to demonstrate fetal development. This confirms the diagnosis of an embryonic pregnancy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.